Vigmed is a Swedish medical technology company founded in 2009, whose mission is to eliminate needlestick injuries and the associated risk of cross infection among healthcare personnel. The company holds a portfolio of patented safety solutions, such as needle protected I.V. and arterial catheters. Our philosophy when developing the first range of products was to provide health care workers with familiar, high quality, affordable products, that provide increased protection from needle sticks. Today, we have marketed products for intravenous and arterial catheterization – all with a built-in automatic safety function. We have launched our products in all of Western Europe and selected markets outside Western Europe. Our short term focus is to establish ourselves in the market with existing or upgraded products, and long term to innovate and launch even better solutions than what is available at the market today. During 2017, Vigmed became part of Greiner Bio-One (GBO), which is a privately held, Austrian company within the MedTech industry. Combining the innovative capabilities and “center of excellence” knowledge within Vigmed with GBOs market position and financial strength is expected to accelerate our growth even further. To drive innovation and set new standards for safety, quality and cost effectiveness are strong driving forces behind the Vigmed team. Vigmed is headquartered in Helsingborg and has today 11 employees.